Orion Oyj
XMUN:OFK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of Orion Oyj (OFK) under the Base Case is 74.78 EUR per share. Compared with the current market price of 100.4 EUR, the stock appears Overvalued by 26% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Orion Does
Orion Oyj is a Finnish pharmaceutical company that develops, manufactures, and sells medicines for people and animals. Its main products include prescription drugs, over-the-counter medicines, and veterinary medicines, with a strong focus on treatments for the central nervous system, cancer care, and animal health. The company also makes active pharmaceutical ingredients and other drug-related products that it sells to partners in the healthcare industry.
- Headquarters
- Finland FI
- Employees
- 4 132
- IPO date
- Jul 3, 2006
Balance Sheet
Recent Events
Latest Earnings Call
Nubeqa remained Orion’s key growth driver, and strong first-nine-month performance and outlook for the rest of the year prompted an upgrade to its 2026 financial outlook.
Open the earnings call- EPS
- €1.19
- Expected
- €1.13
- Surprise
- +5.3%
- Stock, day of the call
- +0.2%
Past 12 months
Continue OFK Research
Decided on Orion? Get an email when OFK reaches the price you’d buy at. Free with an account.
Other Orion listings
What is the Intrinsic Value of one OFK stock?
The intrinsic value for Orion Oyj (OFK) under the Base Case is 74.78 EUR.
Is OFK stock undervalued or overvalued?
Compared with the current market price of 100.4 EUR, the stock appears Overvalued by 26% .